Anúncio
Anúncio

SXTP

SXTP logo

60 Degrees Pharmaceuticals, Inc. Common Stock

0.54
USD
Patrocinado
+0.03
+5.56%
09 de jan., 15:27 UTC -5
Encerrado
exchange

Pós-Mercado

0.59

+0.05
+9.06%

Relatórios de Lucros SXTP

Rácio de surpresa positiva

SXTP separação 2 de 9 últimas estimativas.

22%

Próximo Relatório

Data do Próximo Relatório
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q-- -1 (Revenue/ EPS)
--
/
--

60 Degrees Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On 13 de nov. de 2025, SXTP reported earnings of -0.66 USD per share (EPS) for Q3 25, beating the estimate of -1.23 USD, resulting in a 46.52% surprise. Revenue reached 528.56 mil, compared to an expected 408.00 mil, with a 29.55% difference. The market reacted with a -4.88% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, 60 Degrees Pharmaceuticals, Inc. Common Stock reported EPS of -$0.66, beating estimates by 46.52%, and revenue of $528.56K, 29.55% above expectations.
The stock price moved down -4.88%, changed from $1.23 before the earnings release to $1.17 the day after.
The next earning report is scheduled for --.
Based on -- analistas, 60 Degrees Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio